Literature DB >> 22754953

Alzheimer’s disease: the new promise.

Warren J Strittmatter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22754953      PMCID： PMC3314477          DOI： 10.1172/jci62745

Source DB:  PubMed          Journal:  J Clin Invest        ISSN： 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  7 in total

Review 1.  Testing the right target and right drug at the right stage.

Authors:  Reisa A Sperling; Clifford R Jack; Paul S Aisen
Journal:  Sci Transl Med       Date:  2011-11-30       Impact factor: 17.956

2.  APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt Pathway via the phosphoinositol phosphatase SHIP2.

Authors:  Robert DeKroon; Jennifer B Robinette; Anita B Hjelmeland; Emma Wiggins; Morven Blackwell; Mirta Mihovilovic; Makoto Fujii; John York; Janet Hart; Christopher Kontos; Jeremy Rich; Warren J Strittmatter
Journal:  Circ Res       Date:  2006-09-14       Impact factor: 17.367

Review 3.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics.

Authors:  Eric Karran; Marc Mercken; Bart De Strooper
Journal:  Nat Rev Drug Discov       Date:  2011-08-19       Impact factor: 84.694

4.  Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial.

Authors:  Suzanne Craft; Laura D Baker; Thomas J Montine; Satoshi Minoshima; G Stennis Watson; Amy Claxton; Matthew Arbuckle; Maureen Callaghan; Elaine Tsai; Stephen R Plymate; Pattie S Green; James Leverenz; Donna Cross; Brooke Gerton
Journal:  Arch Neurol       Date:  2011-09-12

5.  Auguste D and Alzheimer's disease.

Authors:  K Maurer; S Volk; H Gerbaldo
Journal:  Lancet       Date:  1997-05-24       Impact factor: 79.321

6.  Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline.

Authors:  Konrad Talbot; Hoau-Yan Wang; Hala Kazi; Li-Ying Han; Kalindi P Bakshi; Andres Stucky; Robert L Fuino; Krista R Kawaguchi; Andrew J Samoyedny; Robert S Wilson; Zoe Arvanitakis; Julie A Schneider; Bryan A Wolf; David A Bennett; John Q Trojanowski; Steven E Arnold
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808

7.  An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer's disease- associated Aβ oligomers.

Authors:  Theresa R Bomfim; Leticia Forny-Germano; Luciana B Sathler; Jordano Brito-Moreira; Jean-Christophe Houzel; Helena Decker; Michael A Silverman; Hala Kazi; Helen M Melo; Paula L McClean; Christian Holscher; Steven E Arnold; Konrad Talbot; William L Klein; Douglas P Munoz; Sergio T Ferreira; Fernanda G De Felice
Journal:  J Clin Invest       Date:  2012-04       Impact factor: 14.808
  7 in total
  2 in total

Review 1.  Emerging links between type 2 diabetes and Alzheimer's disease.

Authors:  Gumpeny R Sridhar; Gumpeny Lakshmi; Gumpeny Nagamani
Journal:  World J Diabetes       Date:  2015-06-10

2.  The independent association of hypertension with cognitive function among older adults with heart failure.

Authors:  Michael L Alosco; Adam M Brickman; Mary Beth Spitznagel; Manfred van Dulmen; Naftali Raz; Ronald Cohen; Lawrence H Sweet; Lisa H Colbert; Richard Josephson; Joel Hughes; Jim Rosneck; John Gunstad
Journal:  J Neurol Sci       Date:  2012-09-29       Impact factor: 3.181
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.